Wikidata

(Q44302205)

English

Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months

scientific article

In more languages

Statements

title
Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12566596
retrieved
1 December 2017
author name string
Rafael Blesa
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12566596
retrieved
1 December 2017
Michael Davidson
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12566596
retrieved
1 December 2017
Alexander Kurz
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12566596
retrieved
1 December 2017
William Reichman
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12566596
retrieved
1 December 2017
Bart van Baelen
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12566596
retrieved
1 December 2017
Susanne Schwalen
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
12566596
retrieved
1 December 2017
publication date
1 January 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
12566596
retrieved
1 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44302205&oldid=2109293784"